VEGF therapy: risky business for established plaques?

Slides:

Advertisements

Similar presentations

RNA interference in biology and disease by Carol A. Sledz, and Bryan R. G. Williams Blood Volume 106(3): August 1, 2005 ©2005 by American Society.

Advertisements

Connexin Mutations in Skin Disease and Hearing Loss David P. Kelsell, Wei-Li Di, Mark J. Houseman The American Journal of Human Genetics Volume 68, Issue.

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.

Gene Preference in Maple Syrup Urine Disease Mary M. Nellis, Dean J. Danner The American Journal of Human Genetics Volume 68, Issue 1, Pages (January.

Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma by Joshua Richter, Natalia Neparidze,

An antiapoptotic role for telomerase RNA in human immune cells independent of telomere integrity or telomerase enzymatic activity by Francesca S. Gazzaniga,

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup

Peopling of Sahul: mtDNA Variation in Aboriginal Australian and Papua New Guinean Populations Alan J. Redd, Mark Stoneking The American Journal of Human.

Tijana Skrepnik, MD, Silvija Gottesman, MD, Baldassarre Stea, MD, PhD

by Toru Takahashi, Toshiaki Yujiri, and Yukio Tanizawa

Intensive hemodialysis—keeping the faith

Defects in DBA: more than meets the eye

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

by Zhenping Zhu Blood Volume 108(6): September 15, 2006

Glis: novel modulators of TCR signaling?

Tax fingerprint in adult T-cell leukemia

A cell by any other name by Narla Mohandas Blood

One giant leap for pediatric AMKL

How I treat elderly patients with myeloma

How to Treat MDS without Stem Cell Transplantation

by Petri Salven, Lasse Teerenhovi, and Heikki Joensuu

Fusion genes in cord blood

What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):

Fluorescent neutrophils throw the spotlight on inflammation

Acute promyelocytic leukemia, microgranular variant

GASing up iron delivery via STAT5

by Ernest Beutler Blood Volume 98(9): November 1, 2001

An actuarial GPS for hemophilic longevity

Stage C or not stage C…? by Claire Dearden Blood

The sting of WASP deficiency: autoimmunity exposed

HU for acute treatment of sickle VOC?

Allogeneic Stem Cell Transplantation in Myelofibrosis

Direct Conversion of Skin Cells into Blood: Alchemy or Science?

Anergy: the CLL cell limbo

Intensive hemodialysis—keeping the faith

Chemokines and chemokine receptors: here, there, and everywhere

Transplantation of Umbilical Cord Blood–Derived Cells for Novel Indications in Regenerative Therapy or Immune Modulation: A Scoping Review of Clinical.

Controversies in Lymphoma: The Role of Hematopoietic Cell Transplantation for Mantle Cell Lymphoma and Peripheral T Cell Lymphoma Peter Dreger, Ginna.

Follicular Lymphoma: Prognostic Factors, Conventional Therapies, and Hematopoietic Cell Transplantation Laurie H. Sehn, Timothy S. Fenske, Ginna G. Laport

High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin.

Premal Lulla, Carlos A. Ramos Molecular Therapy

Erratum The American Journal of Human Genetics

Volume 87, Issue 1, Pages (January 2015)

Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data Brent R. Logan, Mei-Jie Zhang,

Inside This Issue Experimental Hematology

Pauline Damien, David S. Allan

Gerard Socié, K. Scott Baker, Smita Bhatia

674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.

Issues of Aging and Geriatric Medicine: Relevance to Cancer Treatment and Hematopoietic Reconstitution William B. Ershler, Andrew S. Artz, Evan T. Keller

Volume 87, Issue 1, Pages (January 2015)

Chimeric Antigen Receptor–Modified T Cells: Clinical Translation in Stem Cell Transplantation and Beyond Stanley R. Riddell, Michael C. Jensen, Carl.

Blood and Marrow Transplant Handbook

Gregory G. Ginsberg, MD Gastrointestinal Endoscopy

Cancer therapy: Less blood means more sanguinity

Mammen Chandy Biology of Blood and Marrow Transplantation

Praveena Narayanan, Alexandra Wolanskyj, Shawna L. Ehlers, Mark R

Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation: Current Perspectives Brenda M. Sandmaier, Stephen Mackinnon, Richard.

MicroRNA-21 and the Vulnerability of Atherosclerotic Plaques

Treatment versus Transplant for Challenging Hematologic Disorders

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Sickle cells and sickle trait in thrombosis

Mary Eapen Biology of Blood and Marrow Transplantation

Rituximab immunotherapy: it’s getting personal

Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.

A binding relationship with thrombin

by Lapo Alinari, and Kristie A. Blum

Initial treatment of CLL: integrating biology and functional status

Gene editing in hemophilia: a “CRISPR” choice?

Balancing bleeding in brain metastases

Presentation transcript:

VEGF therapy: risky business for established plaques? by Alexandra Kadl, and Norbert Leitinger Blood Volume 109(1):2-3 January 1, 2007 ©2007 by American Society of Hematology

Overexpression of VEGF-A results in a significant increase in plaque size and in a marked accumulation of monocytes. Overexpression of VEGF-A results in a significant increase in plaque size and in a marked accumulation of monocytes. See the complete figure in the article beginning on page 122. Alexandra Kadl, and Norbert Leitinger Blood 2007;109:2-3 ©2007 by American Society of Hematology